Funded Biotechnology Startups in Salt Lake City
Across these 14 recently dated biotechnology rounds in Salt Lake City, one disclosed amount is in a different tier: Sera Prognostics raised $50M on 2025-02…
Across these 14 recently dated biotechnology rounds in Salt Lake City, one disclosed amount is in a different tier: Sera Prognostics raised $50M on 2025-02-10, and Clene Nanomedicine’s $28M (2026-01-09) is the next-largest disclosed figure. Everything else with disclosed amounts sits below those two, including R-Zero’s $105M on 2023-02-14 (the largest disclosed amount in the rows) which dwarfs the rest, while the smallest disclosed round is Applied Biosensors at $680K on 2023-07-07. The dates cluster heavily around late 2022–early 2025, with R-Zero (2023-02-14) and Kiora Pharmaceuticals (2022-11-18) anchoring the earlier half and a tight run in early February 2025: Rebel Medicine at $5M (2025-02-06), iVeena at $3M (2025-02-05), and Sera Prognostics at $50M (2025-02-10). Stage naming is skewed toward incomplete labels: 5 entries show “Series Unknown,” and 1 entry is explicitly “undisclosed,” alongside single-digit counts for Seed (3), Series A (1), Series B (1), and Series C (1).
Most recent rounds
14 shownRelated listings
Frequently asked
Which biotech round is the disclosed outlier, and how far above the next-largest disclosed amount is it?
R-Zero’s disclosed $105M on 2023-02-14 is the standout outlier; the next-largest disclosed amount is Sera Prognostics at $50M on 2025-02-10, with Clene Nanomedicine at $28M on 2026-01-09 trailing further.
Do the most recent dates cluster into a narrow window around early 2025?
Yes. Three entries land within a few days in February 2025: iVeena ($3M, 2025-02-05), Rebel Medicine ($5M, 2025-02-06), and Sera Prognostics ($50M, 2025-02-10), with Clene Nanomedicine following later as the most recent row at $28M on 2026-01-09.
What are the stage-label patterns, and which stages appear most often among disclosed rows?
Stage labeling is incomplete for many entries: 5 are “Series Unknown,” and 1 is “undisclosed.” Among the explicitly labeled rounds, Seed appears 3 times (Applied Biosensors $680K on 2023-07-07; Paterna Biosciences $6M on 2024-10-29; Known Medicine $7M on 2021-08-25), while Series A (Rebel Medicine), Series B (iVeena), and Series C (R-Zero) each appear once.
Are there extremely small disclosed rounds that could distort comparisons for this Salt Lake City biotech list?
Applied Biosensors at $680K (2023-07-07) is the smallest disclosed amount in the rows shown, and Vistim Labs is close to the floor at $10K (2023-06-08) even though those labels are not comparable in stage; the presence of “undisclosed” (Co-Diagnostics on 2023-07-18) also limits clean size ranking.
Which biotech rounds have complete disclosed amounts vs missing amounts, and how many are missing?
11 of the 14 rows show a disclosed dollar amount (e.g., R-Zero $105M on 2023-02-14; Sera Prognostics $50M on 2025-02-10), while 1 row is explicitly “undisclosed” (Co-Diagnostics on 2023-07-18) and 5 rows are labeled “Series Unknown” in the series field (not missing dollar amounts).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.